PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Internal Medicine and Nephrology Unit, Department of Life, Health & Environmental Sciences, University of L\'Aquila, L\'Aquila, Italy.\', \'Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.\', \'Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK.\', \'National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), University College London Hospitals NHS Foundation Trust, London, UK.\', \'Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.\', \'Patient Research Partner, EULAR, Oslo, Norway.\', \'Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Freie Universität und Humboldt-Universität Berlin, Berlin, Germany.\', \'Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & The NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK.\', \'Rheumatology and Clinical Immunology Unit, University of Rome \'Campus Biomedico\' School of Medicine, Rome, Italy.\', \'Department of Hematology, Hôpital Necker, Assistance Publique - Hôpitaux de Paris, Paris, France.\', \'Institut Imagine, Université de Paris, INSERM UMR1183, Paris, France.\', \'Translational and Clinical Research Institute, Newcastle University and Musculoskeletal Unit, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.\', \'Department of Paediatric Rheumatology, Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Bicêtre University Hospital, AP-HP, Le Kremlin-Bicetre, France.\', \'University of Paris Sud Saclay, Paris, France.\', \'Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Netherlands.\', \'Experimental Laboratory of Immunological and Rheumatologic Researches, Istituto Auxologico Italiano IRCCS, Milano, Italy.\', \'Department of Medicine, Rheumatology Clinic, University of Udine, ASUFC Udine, Udine, Italy.\', \'University Hospitals Bristol NHS Foundations Trust, Bristol, UK.\', \'Translational Health Sciences, University of Bristol, Bristol, UK.\', \'Department of Autoimmune Diseases, ICMiD, Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, University of Barcelona, Hospital Clínic, Barcelona, Spain.\', \'Department of Functional Biology, Immunology Area, Faculty of Medicine, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), University of Oviedo, Oviedo, Spain.\', \'Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig-Maximilians University Munich, Munich, Germany.\', \'Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna and Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Wien, Austria.\', \'Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and immunology Center, Amsterdam University Medical Centres, AMC/University of Amsterdam, Amsterdam, Netherlands.\', \'Department of Internal Medicine, Cochin University Hospital, Paris, France; National Referral Centre for Systemic and Autoimmune Diseases, University Paris Descartes, Sorbonne Paris Cité, Paris, France.\', \'Department of Rheumatology, INSERM UMR1184, Le Kremlin Bicêtre, France xavier.mariette@aphp.fr.\', \'Department of Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, INSERM UMR1184, Le Kremlin Bicêtre, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-221366
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34620584
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all